Dr. Charles Perou, Komen Scholar, May Goldman Shaw Distinguished Professor of Molecular Oncology in the Departments of Genetics and Pathology and Laboratory Medicine and Member, UNC Lineberger Comprehensive Cancer Center, received an award from the Susan G. Komen Breast Cancer Research Foundation.

The three-year study will focus on identifying the genetic drivers of the HER2-enriched subtype of HER2+ breast cancer to better understand how this type of breast cancer responds to current therapies, providing new therapeutic targets that could then be tested in a clinical trial.